stocktools
Offerings // Inhibikase Therapeutics, Inc.

IKT offering history

Every offering-related filing in Inhibikase Therapeutics, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 360 filings back to Aug 31, 2018.

Last executed offering
Jul 29, 2026
8-K — priced deal (shares or notes)
Last registration (announced)
Jun 20, 2025
S-3 — capacity, not a sale
Executed, last 12 months
4
424B pricings + 8-K 3.02 sales
Registered, last 12 months
0
S-1/S-3/F-series registrations
DateFilingWhat it means
Jul 29, 20268-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Dec 19, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Nov 21, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Nov 20, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jun 27, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jun 20, 2025S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Feb 24, 20258-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Jan 16, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jan 10, 2025S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Dec 5, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Dec 5, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Dec 3, 2024S-3/A →REGISTEREDS-3/A registration — capacity to sell shares, not a sale yet
Nov 18, 2024S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Oct 10, 20248-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Jun 27, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Jun 26, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jun 18, 2024S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
May 22, 2024424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
May 20, 2024424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
May 20, 20248-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
May 15, 2024RW →WITHDRAWNRegistration withdrawn
May 9, 2024S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
May 9, 2024S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Apr 29, 2024S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Apr 25, 2024S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Apr 19, 2024S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Feb 1, 2024424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Apr 4, 2023424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Apr 4, 2023EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Feb 8, 2023424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Feb 7, 2023EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Feb 2, 2023S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Jan 27, 2023424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jan 26, 20238-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
May 17, 2022424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Feb 11, 2022EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Feb 7, 2022S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Jun 17, 2021424B4 →EXECUTEDFinal prospectus — offering priced (typical for IPOs and marketed share deals)
Jun 15, 2021EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jun 11, 2021S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
IKT offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full IKT workspace →
IKT offering FAQ

When did IKT last execute an offering?

Per SEC filings, Inhibikase Therapeutics, Inc.'s most recent priced offering document is a 8-K filed 2026-07-29. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did IKT last announce or register an offering?

The most recent registration is a S-3 filed 2025-06-20. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.